Last reviewed · How we verify

NCT04855019

Post Surgical Pain in Arthroscopic Shoulder

Completed NA Last updated 2 November 2021
What this trial tests

NA trial testing shoulder periarticular injection, suprascapular and axillary nerve block in Total Shoulder Arthroplasty in 60 participants. Completed in 1 October 2021.

Timeline
20 May 2021
Primary endpoint
15 September 2021
1 October 2021

Quick facts

Lead sponsorNamik Kemal University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment60
Start date20 May 2021
Primary completion15 September 2021
Estimated completion1 October 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Namik Kemal University

Who can join

Adults 18 to 65, any sex, with Total Shoulder Arthroplasty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Postoperative multimodal analgesia methods occupy an essential place in modern anesthesia. The postoperative results of opioid analgesia are now at the bottom of the current problems due to its side effects. Longer-acting local anesthetics are now effective agents of analgesia. Investigators aimed to compare the two routine methods. Ultrasonic nerve blocks are the most important of multimodal analgesia in modern anesthesia. Suprascapular and axillary nerve blocks are routinely used as a safe method. It is a routine method used by periarticular local anesthetic surgeons. İnvestigators decided to compare which method effectively follows these two methods with the postoperative 24 pain scale method.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Total Shoulder Arthroplasty

Currently open trials in the same condition.

Other Namik Kemal University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04855019.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing